Nationwide survey of the secondary findings in cancer genomic profiling: survey including liquid biopsy
- 17 September 2024
- journal article
- research article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 70 (1) , 33-40
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Is legislation to prevent genetic discrimination necessary in Japan? An overview of the current policies and public attitudesJournal of Human Genetics, 2023
- Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facilityJournal of Human Genetics, 2023
- Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendationsAnnals of Oncology, 2022
- Expectations, concerns, and attitudes regarding whole-genome sequencing studies: a survey of cancer patients, families, and the public in JapanJournal of Human Genetics, 2022
- The role of the Genetic Counsellor in the multidisciplinary team: the perception of geneticists in EuropeEuropean Journal of Human Genetics, 2022
- Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire surveyJournal of Human Genetics, 2022
- Physicians’ perceptions of the factors influencing disclosure of secondary findings in tumour genomic profiling in Japan: a qualitative studyEuropean Journal of Human Genetics, 2021
- Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsJAMA Oncology, 2021
- The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in JapanInternational Journal of Clinical Oncology, 2021
- Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAJAMA Oncology, 2016